PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of PS-341 in treating patients who have
advanced solid tumors or lymphoma that have not responded to previous treatment.
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health